“Atlantic Retina, Dover and Salisbury staff caring and professional. Dr. Schwartz is superior in his profession.”
How Fast Does Geographic Atrophy Progress?
How Quickly the Damaged Area Grows
Geographic atrophy does not progress at the same rate in every eye. Understanding the range of typical growth, and which factors tend to drive a faster pace, helps you and your retina specialist plan the right monitoring schedule.
When researchers pool data across large groups, geographic atrophy tends to grow somewhere between 0.53 and 2.6 square millimeters per year, with a middle value near 1.78 square millimeters. A square millimeter is roughly the size of a pinhead, so changes that are significant on a retinal scan are often invisible to you until the edge of the damaged area gets close to your central vision. Your personal rate matters more than any group average, and two scans taken a year apart give your doctor a real measurement to work with.
Larger patches tend to expand faster than smaller ones, which shapes how closely your team monitors you.
- Patches smaller than 1.3 square millimeters grow about 0.8 square millimeters per year on average, and this group often has no symptoms yet
- Patches between 1.3 and 8.3 square millimeters grow about 2.1 square millimeters per year, and this is the most common size range at the time of diagnosis
- Patches larger than 8.3 square millimeters grow about 3.0 square millimeters per year, and closer follow-up is typical
These figures describe groups of patients, not a schedule for any individual eye. They are most useful as a framework for understanding why your follow-up interval may differ from someone else's.
Atrophy tends to expand faster away from the fovea than toward it, which is part of why central reading vision often lasts longer than the raw area measurements might suggest. The shape and pattern of the damaged area, including whether it appears as one connected patch or several separate pieces, also affects how quickly it enlarges. A specific deposit pattern called reticular pseudodrusen has been linked with faster enlargement as well.
On average, the interval between atrophy that spares the center and atrophy that involves the center is around three years. In one large study, 57 out of every 100 eyes that started with off-center atrophy had reached the center within four years. That means a meaningful number of eyes still had a spared center at the four-year mark. Position is the key variable: an edge that sits close to the fovea has much less distance to travel than one farther away.
What Makes Progression Faster or Slower
Several factors consistently appear in research as predictors of how quickly geographic atrophy grows. Some of these are visible on your retinal scans, and none of them are things you caused.
The characteristics most consistently linked to faster enlargement include atrophy that is divided into several separate pieces rather than one connected area, a starting size in the middle range, and damage that currently spares the center of vision. None of these factors determines your outcome. They mainly guide how frequently your scans are scheduled and how closely your retina specialist watches for changes.
The two eyes tend to follow a similar course. Having atrophy in both eyes is one of the features associated with faster progression, and the condition of the second eye is one of the most reliably confirmed predictors of pace. This is also the reason checking each eye separately at home is so important. A stronger eye covers for a weaker one so well that changes can go unnoticed for months.
Age, family history, and genetic background are fixed factors. Smoking is not. Guidelines consistently recommend that people with macular degeneration who smoke be counseled to stop, both for their eye health and their general health. It is worth knowing, however, that in large clinical studies, stopping smoking was not shown to slow the growth of atrophy that had already formed. Quitting still matters for preventing further damage and supporting your overall health.
Symptoms to Watch For as the Condition Advances
Geographic atrophy often produces no symptoms in its early stages, especially when the damage sits away from center and the other eye is healthy. Knowing what changes to watch for, and which ones require urgent attention, is an essential part of living with this condition.
As dry macular degeneration advances, common symptoms include difficulty reading in dim light, colors that look less vivid than they used to, trouble driving at night, and dark or blurry areas in the middle of vision. Better task lighting, stronger reading glasses, and magnification devices often restore a meaningful amount of function at this stage, so mention these difficulties to your care team rather than simply adjusting around them.
People rarely describe the missing area as a dark patch. More often, letters disappear from the middle of a word, a face looks smudged where the eyes should be, or a spot seems to shift as you look in different directions. Even when the center is affected, complete blindness does not occur. Side vision remains intact, and it supports walking, navigation, and a great deal of daily independence.
One change does not fit the expected slow pattern of geographic atrophy: straight lines that suddenly appear bent or wavy, or a new blurred area that develops over hours or days. This may signal wet macular degeneration, a related condition in which leaky new blood vessels grow under the retina and can cause rapid vision loss. Wet macular degeneration can develop on top of existing atrophy and moves on a timeline of days, not years. Detecting it early is associated with better long-term vision than detecting it late, which is why this symptom should be reported to your retina specialist the same day or the next morning, not at your next scheduled appointment.
How Your Retina Specialist Tracks Your Progression
Measuring how quickly your atrophy is growing requires retinal imaging, not just a reading chart. The tools available today allow our team to track the size and location of the damaged area with precision over time.
Fundus photography produces a detailed color image of the retina. Fundus autofluorescence imaging highlights the edges of the atrophied tissue with particular clarity, making it well suited for measuring area over time. Optical coherence tomography, commonly called OCT, produces a cross-sectional view of the retinal layers, allowing our team to assess the depth of damage and detect any fluid that might indicate a shift toward the wet form. All of these tests are quick and painless.
This surprises many patients, and there is a straightforward reason for it. A standard reading chart tests one small point of the retina, the fovea, and a growing patch may not have reached that point yet. Chart vision can remain stable for a considerable time while the atrophy area expands. Reading speed, vision in dim light, and the ability to handle glare often decline before the reading chart reflects any change. Describing those difficulties to your retina specialist is valuable, because imaging and your reported experience together shape your follow-up plan more accurately than the chart score alone.
Comparing images taken at each visit, side by side, is one of the most useful ways to understand your personal rate of change. Seeing the actual difference in the size and position of the damaged area between two visits makes the otherwise invisible process visible. This kind of serial comparison at every visit is a practice we follow closely, because it gives both you and our team a documented record of how your condition is behaving over time.
What Can Be Done to Slow Geographic Atrophy
Treatment options for geographic atrophy have expanded meaningfully in recent years. There is no treatment that restores tissue that has already been lost, but there are tools that may slow how quickly new tissue is affected.
Two medicines, pegcetacoplan and avacincaptad pegol, are approved in the United States for geographic atrophy. Both are given as injections into the eye every one to two months, and both work by dampening the complement system, which is a branch of the immune system that appears to drive the tissue loss in this condition. These are the first treatments directed at the atrophy itself rather than its secondary effects.
In phase 3 clinical trials, these injections slowed the growth of the atrophy area by roughly one-eighth to one-quarter compared with sham injections over one to two years. However, they did not improve the vision measures the trials were designed to test. Reported risks include new wet macular degeneration, inflammation inside the eye, and, in some cases, damage to the optic nerve from reduced blood supply. The decision to begin these injections involves a genuine weighing of modest benefit against real risk, and it is one your retina specialist will help you think through carefully based on your specific situation.
Antioxidant vitamin and mineral supplements based on the AREDS and AREDS2 formulas are considered for people who have reached the intermediate or advanced stage of macular degeneration in at least one eye. The studied benefit is slowing disease progression at earlier stages, not reversing atrophy that already exists. Ask our team whether the formula is appropriate for you given your other health conditions and medications.
Alongside supplements, not smoking, eating a diet rich in leafy green vegetables and fish, and managing blood pressure and cholesterol are the general lifestyle measures recommended for macular degeneration. These steps support your overall health and may help protect the retinal tissue you still have.
Vision rehabilitation is a recognized and important part of macular degeneration care, and it works best when introduced early. Task lighting, magnifiers, high-contrast displays, and large-print materials are practical tools that become easier to build habits around while usable central vision remains. A low-vision specialist or occupational therapist can help you identify the right combination of tools for your daily routine. Ask for a referral if you have not already seen one.
Understanding Your Longer-Term Outlook
A realistic outlook on geographic atrophy helps you plan and prepare, rather than simply wait. The numbers from long-term studies can be unsettling if read without context, so it helps to understand what they do and do not tell you.
In a series of patients followed for a median of three years, about one-third of eyes had lost three lines of vision on the reading chart by the two-year mark, and about half had lost three lines by four years. Among eyes that started with reasonably good vision, roughly one-quarter had dropped to 20/200 or worse by four years. These are meaningful figures, and they are not universal. Roughly half of eyes had not lost three lines of vision at the four-year point, and outcomes vary considerably depending on where the atrophy sits and how quickly it has been moving.
Among eyes that developed geographic atrophy in one large study, about 29 out of every 100 went on to develop wet macular degeneration within four years. That means about 71 out of every 100 did not. The practical response is a clear plan: consistent home monitoring with one eye at a time, and a same-week call to your retina specialist if straight lines change or a new blurred area appears. Wet macular degeneration is treatable, especially when caught early.
Geographic atrophy worsens gradually, and no treatment restores tissue that has already been lost. What is realistic is a slower rate of change for some patients with treatment, early detection of the wet form if it develops, and vision support that keeps reading, cooking, and moving around independently workable for many years. Most people with this diagnosis maintain meaningful independence for a long time. Planning around that realistic picture is more accurate and more useful than planning for the worst.
When to Contact Your Retina Specialist
Knowing when to call between appointments is just as important as keeping your scheduled visits. Some changes are expected and gradual. Others require prompt attention because they may signal a faster, treatable problem.
Contact your retina specialist without waiting for your next scheduled appointment if you notice any of the following in either eye.
- Straight lines, door frames, or text that suddenly appear bent or wavy
- A new blurred or blank area in the center of your vision that appeared over hours or days
- A sudden drop in how clearly one eye sees when the other is covered
- A new dark spot that grows noticeably over a week or two
- Any distortion that was not present at your last visit
These symptoms may indicate that wet macular degeneration has developed. That condition is treatable and time-sensitive. Being seen and reassured costs one appointment, so make the call rather than waiting.
Between clinic visits, monitoring each eye separately at home is the most practical early-warning system available. An Amsler grid, which is a square printed grid with a central dot, is commonly used for this purpose. Cover one eye, focus on the central dot, and note whether any lines look wavy, missing, or distorted. Then repeat with the other eye. Attaching this habit to something you already do every morning, such as making coffee, makes it far more likely to happen consistently.
Frequently Asked Questions
These questions address common points of uncertainty that go beyond the explanations above, including how to apply this information to your own situation and what steps to take next.
Your rate is calculated by comparing the size of the atrophy area on two scans taken at different visits, typically a year apart. The difference in area divided by the time between scans gives a measured growth rate specific to your eye. This is more informative than population averages because it reflects your actual biology, not a group estimate. If you have only had one scan, the next scheduled visit is the point at which your rate can first be calculated.
There is no evidence that reading, screen use, or close work speeds up geographic atrophy, nor that resting your eyes slows it. The damage sits in the support layer beneath the retina and follows its own biological course. Use whatever lighting, font size, and magnification makes reading comfortable, because staying engaged with reading and daily activities does not harm the retina and supports your quality of life.
This is a nuanced decision that depends on the size and location of your atrophy, the state of your other eye, how quickly the patch has been growing, and your tolerance for the visit frequency these injections require. Clinical trials showed that the injections slowed lesion growth but did not improve measured vision over one to two years, and they carry real risks. There is no universal answer. Asking your retina specialist what specific goal the treatment would serve in your case is the right starting point.
Many people drive safely in the early stages, and the honest answer depends on your measured vision and the licensing standards in your state, not on the diagnosis alone. Difficulty with night driving and glare often appears before daytime vision on familiar routes is affected. Have your vision formally assessed, ask your retina specialist what to watch for, and think about a gradual transition plan before you are in a position where driving becomes unsafe unexpectedly.
The two eyes do not directly affect each other biologically, but the state of your second eye is one of the consistently confirmed predictors of progression pace in the affected eye. More practically, a stronger eye naturally compensates for a weaker one, which means changes in the more affected eye can go unnoticed for months unless you check each eye separately. The home monitoring habit described above is the most direct way to catch that kind of change early.
A focused list makes every appointment more useful. Consider asking how large the atrophy is now and how much it has changed since the last scan, how close the edge of the damaged area is to your central vision, whether the atrophy appears as one connected patch or several separate pieces, whether an AREDS2-formula supplement is appropriate for your situation, and what specific symptom should prompt you to call before your next scheduled visit. Writing these down before you arrive ensures they get answered even in a short visit.
See Our Team at Atlantic Retina Center
Our team of fellowship-trained, ABO board-certified retina specialists has provided dedicated care for patients across the Eastern Shore of Maryland and central and southern Delaware since 2004. At Atlantic Retina Center, we focus exclusively on the retina, vitreous, and macula, and we use serial retinal imaging at every visit to track your condition accurately over time. If you have been diagnosed with geographic atrophy or are concerned about changes in your vision, we encourage you to schedule an appointment so we can measure your personal rate of progression and build a monitoring plan around it.